This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Current status and future perspectives in targeted therapy of NPM1-mutated AML
Leukemia Open Access 25 August 2022
-
Genome-wide association study identifies susceptibility loci for acute myeloid leukemia
Nature Communications Open Access 29 October 2021
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Tallman MS . New agents for the treatment of acute myeloid leukemia. Best Pract Res Clin Haematol 2006; 19: 311–320.
Klammer MandRoddie PH . Current progress in the development of a cell-based vaccine for the immunotherapy of acute myeloid leukemia. Expert Rev Vaccines 2006; 5: 211–222.
Falini B, Mecucci C, Tiacci E, Alcalay M, Rosati R, Pasqualucci L et al. Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype. N Engl J Med 2005; 352: 254–266.
Falini B, Nicoletti I, Martelli MF, Mecucci C . Acute myeloid leukemia carrying cytoplasmic/mutated nucleophosmin (NPMc+AML): biologic and clinical features. Blood 2007; 109: 874–885.
Falini B, Bolli N, Shan J, Martelli MP, Liso A, Pucciarini A et al. Both carboxy-terminus NES motif and mutated tryptophan(s) are crucial for aberrant nuclear export of nucleophosmin leukemic mutants in NPMc+AML. Blood 2006; 107: 4514–4523.
De Groot AS, Rayner J, Martin W . Modelling the immunogenicity of therapeutic proteins using T cell epitope mapping. Dev Biol (Basel) 2003; 112: 71–80.
De Groot AS, Jesdale B, Martin W, Saint Aubin C, Sbai H, Bosma A et al. Mapping cross-clade HIV-1 vaccine epitopes using a bioinformatics approach. Vaccine 2003; 21: 4486–4504.
Altman JD, Moss PA, Goulder PJ, Barouch DH, McHeyzer-Williams MG, Bell JI et al. Phenotypic analysis of antigen-specific T lymphocytes. Science 1996; 274: 94–96.
Callan MF, Tan L, Annels N, Ogg GS, Wilson JD, O'Callaghan CA et al. Direct visualization of antigen-specific CD8+T cells during the primary immune response to Epstein–Barr virus In vivo. J Exp Med 1998; 187: 1395–1402.
Brodsky FM, Parham P . Monomorphic anti-HLA-A,B,C monoclonal antibodies detecting molecular subunits and combinatorial determinants. J Immunol 1982; 128: 129–135.
Wesierska-Gadek J, Penner E, Hitchman E, Kier P, Sauermann G . Nucleolar proteins B23 and C23 as target antigens in chronic graft-versus-host disease. Blood 1992; 79: 1081–1086.
Acknowledgements
This work was supported by the Associazione Italiana per la Ricerca sul Cancro (AIRC), University of Foggia Research Grants 2004–2005 and by grants from the Fondation contre le Cancer, Brussels, Belgium. Brunangelo Falini applied for a patent on the clinical use of NPM mutants. The other authors report no potential conflicts of interest.
Author information
Authors and Affiliations
Corresponding authors
Additional information
Authors' contributions: AL designed the study, performed experiments, wrote manuscript draft; DC, RB and PC performed experiments and revised manuscript draft; GS and MPM treated patients, provided sample material, revised manuscript draft; RB performed experiments and revised manuscript draft; ADG and WM performed in silico experiments and revised manuscript; BF supervised the study and revised the manuscript.
Rights and permissions
About this article
Cite this article
Liso, A., Colau, D., Benmaamar, R. et al. Nucleophosmin leukaemic mutants contain C-terminus peptides that bind HLA class I molecules. Leukemia 22, 424–426 (2008). https://doi.org/10.1038/sj.leu.2404887
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2404887
This article is cited by
-
Current status and future perspectives in targeted therapy of NPM1-mutated AML
Leukemia (2022)
-
Genome-wide association study identifies susceptibility loci for acute myeloid leukemia
Nature Communications (2021)
-
Altered nucleophosmin transport in acute myeloid leukaemia with mutated NPM1: molecular basis and clinical implications
Leukemia (2009)